28.01.2013 Views

WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...

WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...

WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Safety of Medicines<br />

to copy, combinatorial, easy to incorporate, and<br />

not require regulatory approval and may include<br />

user education or deterrents to counterfeiting.<br />

The Pharmaceutical Security Institute (PSI)<br />

represents a group of multinational pharmaceutical<br />

companies . Its role is to combat counterfeiting<br />

through collection, collation and dissemination of<br />

information and to identify and satisfy training<br />

needs. <strong>Drug</strong> investigations by law enforcement<br />

agencies are often under-resourced due to other<br />

crime priorities. PSI key findings in 2003 concluded<br />

that of 327 reported incidents of crime in<br />

pharmaceuticals, 81% involved counterfeits. Most<br />

incidents occurred in the USA, followed by India<br />

and China. A key trend indicates that counterfeiting<br />

operations are small. In all, 363 people were<br />

arrested with an average value of seizure at US$<br />

3 million. Fifty-three percent of arrests were made<br />

at the point of sale; 13% were manufacturers and<br />

5% were at borders. The US market is predicted<br />

to become an attractive target for counterfeit<br />

medicines and drug diversion. International mail is<br />

highlighted as a distribution corridor readily<br />

exploited by medicine traffickers.<br />

A presentation from the self medication industry<br />

provided statistical information in relation to the<br />

prevalence of counterfeits in Latin America and<br />

globally. It confirmed that counterfeit drugs pose a<br />

significant public health risk and stated that<br />

counterfeiting involves established, sophisticated,<br />

regional criminal organizations and international<br />

organized crime. Factors that make counterfeiting<br />

a widespread activity are:<br />

• Lack of access to many drugs, making lowpriced<br />

counterfeit products attractive.<br />

• Possibility of selling counterfeit drugs from<br />

varied outlets.<br />

• Sale of products without a physician’s prescription<br />

facilitates the selling of fake or counterfeit<br />

products<br />

• Outside of pharmacies, vendors do not posses<br />

the same ability to detect counterfeit products<br />

as pharmacists do.<br />

• Counterfeiting is not a specific crime and<br />

inadequate penalties are applied to drug<br />

counterfeiting.<br />

• Lack of intellectual property protection.<br />

134<br />

<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong> <strong>Vol</strong> <strong>18</strong>, <strong>No</strong>. 2, <strong>2004</strong><br />

• Existence of free trade zones.<br />

• Internet sales leading to cross-border trade in<br />

counterfeits.<br />

Factors that are successful in combating counterfeiting<br />

are:<br />

• Interagency cooperation.<br />

• Categorizing counterfeiting as a specific crime.<br />

• Establishment of stiffer penalties.<br />

• Monitoring of wholesalers and pharmacies.<br />

• The development of best practice manuals on<br />

distribution and dispensing of medicines.<br />

• Consumer education.<br />

In conclusion, essential benefits could be gained<br />

from collaboration between the pharmaceutical<br />

industry and regulators through development of a<br />

comprehensive plan.<br />

E-commerce and challenges<br />

to pharmaceutical trading<br />

Sale of drugs on the Internet has both positive<br />

and negative aspects. Prescription drug sales on<br />

the Internet can provide benefits to consumers,<br />

especially to the disabled or homebound patients<br />

who cannot move easily. It is convenient for<br />

shopping 24 hours a day and gives privacy and<br />

anonymity to those who do not want to discuss<br />

their medical condition in a public place. However,<br />

the negative aspects include possible sale of<br />

unapproved new drugs, absence of doctor/patient<br />

relationship and possibility of obtaining information<br />

on correct use, dispensing of prescription<br />

drugs without prescription, and availability of<br />

products with fraudulent claims.<br />

The United States Food and <strong>Drug</strong> Administration<br />

has taken steps to customize and expand its<br />

enforcement efforts by setting priorities, improving<br />

data acquisition, and coordinating case assessment.<br />

This has resulted in the evaluation of over<br />

400 websites and an increased number of civil<br />

and criminal actions, improved collaboration with<br />

international regulatory officials and the issuance<br />

of cyber letters. Hard copies of each cyber letter<br />

are sent to the website operator, the US Customs<br />

Service and the regulatory authority officials in the<br />

country in which the operator is based. Other

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!